The Fund is a bottom-up stock picking strategy with rigorous fundamental analysis at the company level, focusing on well managedbusinesses who are positioned in areas of the economy with long-term thematic drivers. While the Fund can invest across the whole market cap. range, there is typically a tilt towards small/mid cap stocks due to the impact screening.
The Fund remains the only Australian equities impact fund certified by RIAA.
We participated in Frontier Energy’s $11.5 million capital raise which will allow the Company to complete their debt financing and fund the security deposit required under the Reserve Capacity Mechanism for the Stage One development of the WaroonaRenewable Energy Project.
The standout performer for the month and year has been 4D Medical. The company has developed proprietary software, with patented algorithms, that enables new levels of analysis of lung imaging for earlier detection and better management of respiratory diseases, such as asthma, COPD, cystic fibrosis, and cancer. The share price rose from 47c at the start of the year to $3.93 at year end.
Read the full report NorthStar December 2025 Monthly Report